Profarma Distribuidora de Produtos Farmacêuticos S.A. Stock
Equities
PFRM3
BRPFRMACNOR1
Drug Retailers
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.78 BRL | -2.36% | -5.41% | -5.41% |
Sales 2022 | 7.82B 1.52B | Sales 2023 | 8.66B 1.69B | Capitalization | 748M 146M |
---|---|---|---|---|---|
Net income 2022 | 80M 15.58M | Net income 2023 | 70M 13.64M | EV / Sales 2022 | 0.17 x |
Net Debt 2022 | 841M 164M | Net Debt 2023 | 950M 185M | EV / Sales 2023 | 0.2 x |
P/E ratio 2022 |
5.56
x | P/E ratio 2023 |
10.6
x | Employees | 7,077 |
Yield 2022 |
4.72% | Yield 2023 |
1.9% | Free-Float | 32.86% |
1 day | -2.70% | ||
1 week | -5.57% | ||
Current month | -0.52% | ||
1 month | +2.49% | ||
3 months | +25.76% | ||
6 months | +65.99% | ||
Current year | -5.57% |
Managers | Title | Age | Since |
---|---|---|---|
Sammy Birmarcker
CEO | Chief Executive Officer | 55 | 85-12-31 |
Director of Finance/CFO | 66 | 92-12-31 | |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Sammy Birmarcker
CEO | Chief Executive Officer | 55 | 85-12-31 |
Founder | 89 | 61-04-30 | |
Carlos Gros
BRD | Director/Board Member | - | 20-06-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +0.53% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 5.78 | -2.36% | 158 500 |
24-04-30 | 5.76 | -3.84% | 137,500 |
24-04-29 | 5.99 | +1.01% | 263,500 |
24-04-26 | 5.93 | -0.34% | 376,600 |
24-04-25 | 5.95 | -5.10% | 310,800 |
Delayed Quote Sao Paulo, May 02, 2024 at 09:56 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-5.57% | 136M | |
-33.67% | 14.96B | |
-23.15% | 11.07B | |
+9.74% | 6.13B | |
-22.64% | 6.08B | |
-10.91% | 5.98B | |
+0.88% | 4.76B | |
+53.60% | 4.36B | |
-10.49% | 3.73B | |
-12.53% | 3.43B |
- Stock Market
- Equities
- PFRM3 Stock